BMP-3 and BMP-6 Structures Illuminate the Nature of Binding Specificity with Receptors,
- 1 October 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 46 (43), 12238-12247
- https://doi.org/10.1021/bi700907k
Abstract
Bone morphogenetic proteins (BMPs) are extracellular messenger ligands involved in controlling a wide array of developmental and intercellular signaling processes. To initiate their specific intracellular signaling pathways, the ligands recognize and bind two structurally related serine/threonine kinase receptors, termed type I and type II, on the cell surface. Here, we present the crystal structures of BMP-3 and BMP-6, of which BMP-3 has remained poorly understood with respect to its receptor identity, affinity, and specificity. Using surface plasmon resonance (BIAcore) we show that BMP-3 binds Activin Receptor type II (ActRII) with Kd ≈ 1.8 μM but ActRIIb with 30-fold higher affinity at Kd ≈ 53 nM. This low affinity for ActRII may involve Ser-28 and Asp-33 of BMP-3, which are found only in BMP-3's type II receptor-binding interfaces. Point mutations of either residue to alanine results in up to 20-fold higher affinity to either receptor. We further demonstrate by Smad-based whole cell luciferase assays that the increased affinity of BMP-3S28A to ActRII enables the ligand's signaling ability to a level comparable to that of BMP-6. Focusing on BMP-3's preference for ActRIIb, we find that Lys-76 of ActRII and the structurally equivalent Glu-76 of ActRIIb are distinct between the two receptors. We demonstrate that ActRIIbE76K and ActRII bind BMP-3 with similar affinity, indicating BMP-3 receptor specificity is controlled by the interaction of Lys-30 of BMP-3 with Glu-76 of ActRIIb. These studies illustrate how a single amino acid can regulate the specificity of ligand−receptor binding and potentially alter biological signaling and function in vivo.Keywords
This publication has 22 references indexed in Scilit:
- Bone Morphogenetic Protein 1 Prodomain Specifically Binds and Regulates Signaling by Bone Morphogenetic Proteins 2 and 4Published by Elsevier BV ,2007
- Three Key Residues Underlie the Differential Affinity of the TGFβ Isoforms for the TGFβ Type II ReceptorJournal of Molecular Biology, 2006
- Osteogenic differentiation of human mesenchymal stem cells is regulated by bone morphogenetic protein‐6Journal of Cellular Biochemistry, 2005
- Involvement of Endogenous Bone Morphogenetic Protein (BMP) 2 and BMP6 in Bone FormationPublished by Elsevier BV ,2005
- A Single Residue of GDF-5 Defines Binding Specificity to BMP Receptor IBJournal of Molecular Biology, 2005
- Modulation of activin and BMP signalingMolecular and Cellular Endocrinology, 2004
- Gene therapy for tissue regenerationJournal of Cellular Biochemistry, 2003
- Direct Binding of Smad1 and Smad4 to Two Distinct Motifs Mediates Bone Morphogenetic Protein-specific Transcriptional Activation ofId1 GenePublished by Elsevier BV ,2002
- Identification of Two Amino Acids in Activin A That Are Important for Biological Activity and Binding to the Activin Type II ReceptorsPublished by Elsevier BV ,1999
- Signal transduction by members of the transforming growth factor-β superfamilyCytokine & Growth Factor Reviews, 1996